Channing Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.3M | Buy |
101,884
+43,875
| +76% | +$4.86M | 0.31% | 52 |
|
|
2025
Q1 | $6.5M | Sell |
58,009
-40,649
| -41% | -$4.55M | 0.2% | 91 |
|
|
2024
Q4 | $9.11M | Sell |
98,658
-6,347
| -6% | -$586K | 0.24% | 72 |
|
|
2024
Q3 | $8.8M | Buy |
+105,005
| New | +$8.8M | 0.23% | 80 |
|
|
2020
Q1 | – | Sell |
-124,753
| Closed | -$8.11M | – | 115 |
|
|
2019
Q4 | $8.11M | Sell |
124,753
-577
| -0.5% | -$37.5K | 0.38% | 78 |
|
|
2019
Q3 | $7.94M | Buy |
125,330
+12,416
| +11% | +$787K | 0.37% | 74 |
|
|
2019
Q2 | $7.63M | Buy |
112,914
+21,225
| +23% | +$1.43M | 0.35% | 70 |
|
|
2019
Q1 | $5.96M | Buy |
+91,689
| New | +$5.96M | 0.28% | 85 |
|
|
2018
Q2 | – | Sell |
-110,567
| Closed | -$8.34M | – | 107 |
|
|
2018
Q1 | $8.34M | Buy |
110,567
+149
| +0.1% | +$11.2K | 0.29% | 73 |
|
|
2017
Q4 | $7.91M | Buy |
110,418
+3
| +0% | +$215 | 0.27% | 80 |
|
|
2017
Q3 | $8.95M | Buy |
110,415
+3,675
| +3% | +$298K | 0.34% | 69 |
|
|
2017
Q2 | $7.56M | Buy |
106,740
+5,216
| +5% | +$369K | 0.3% | 76 |
|
|
2017
Q1 | $6.9M | Buy |
101,524
+14,956
| +17% | +$1.02M | 0.25% | 82 |
|
|
2016
Q4 | $6.2M | Sell |
86,568
-20,290
| -19% | -$1.45M | 0.22% | 88 |
|
|
2016
Q3 | $8.46M | Buy |
106,858
+7,015
| +7% | +$555K | 0.34% | 74 |
|
|
2016
Q2 | $8.33M | Buy |
+99,843
| New | +$8.33M | 0.35% | 72 |
|